TURP has been considered the gold standard for surgical treatment of BPH for many years. Symptoms relief, improvement in maximum flow rate and reduction of post void residual urine have been reported in several experiences. Nevertheless, concerns have been reported in terms of safety outcomes: intracapsular perforation, TUR syndrome, bleeding.
In the recent years the use of new forms of energy and devices such as bipolar resector, Ho: YAG and potassium-titanyl-phosphate laser are challenging the role of traditional TURP for BPH surgical treatment.
In 1999 TURP represented 81% of surgical treatment for BPH versus 39% in 2005. We have analyzed guidelines and recent literature to evaluate the role of the most relevant new surgical approaches compared to TURP for the treatment of BPH.
HoH.S.S., ChengC.W.S.. (2008) Bipolar transurethral resection of prostate: a new reference standard?Curr Opin Urol.18: 50–55.
11.
SmithD., KhoubehiB., PatelA.. (2005) Bipolar electrosurgery for benign prostatic hyperplasia: transurethral electro-vaporization and resection of the prostate.Curr Opin Urol.15: 95–100.
12.
AutorinoR., DamianoR., Di LorenzoG., QuartoG., PerdonaS., D'ArmientoM. (2009) Four-year outcome of a prospective randomised trial comparing bipolar plasmakinetic and monopolar transurethral resection of the prostate.Eur Urol.55: 922–931.
13.
AhyaiS.A., GillingP., KaplanS.A., KuntzR.M., MadersbacherS., MontorsiF. (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement.Eur Urol.58: 384–397.
14.
SerrettaV., MorgiaG., FondacaroL., CurtoG., Lo biancoA., PirritanoD. (2002) Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: a contemporary series of 1800 interventions.Urology.60: 623–627.
15.
MarianoM.B., GraziottinT.M., TefilliM.V.. (2002) Laparoscopic prostatectomy with vascular control for benign prostatic hyperplasia.J Urol.167: 2528–2529.
16.
McCulloughT.C., HeldweinF.L., SoonS.J., GalianoM., BarretE., CathelineauX. (2009) Laparoscopic versus open simple prostatectomy: an evaluation of morbidity.J Endourol.23: 129–133.
17.
BaumertH., BallaroA., DugardinF., KaisaryA.V.. (2006) Laparoscopic versus open simple prostatectomy: a comparative study.J Urol.175: 1691–1694.
CoelhoR.F., ChauhanS., SivaramanA., PalmerK.J., OrvietoM.A., RoccoB. (2011) Modified technique of robotic-assisted simple prostatectomy: advantages of a vesicourethral anastomosis.BJU Int, in press.
22.
CostelloA.J., JohnsonD.E., BoltonD.M.. (1992) Nd: YAG laser ablation of the prostate as a treatment for benign prostatic hypertrophy.Lasers Surg Med.12: 121–124.
LeeR., GonzalezR.R., TeA.E.. (2006) The evolution of photoselective vaporization prostatectomy (PVP): advancing the surgical treatment of benign prostatic hyperplasia.World J Urol.24: 405–409.
26.
de la RosetteJ., AlivizatosG.. (2006) Lasers for the treatment of bladder outlet obstruction: are they challenging conventional treatment modalities?Eur Urol.50: 418–420.
27.
SekiN., NomuraH., YamaguchiA., NaitoS.. (2008) Evaluation of the learning curve for photoselective vaporization of the prostate over the course of 74 cases.J Endourol.22: 1731–1735.
28.
ShahH.N., MahajanA.P., HegdeS.S., BansalM.B.. (2007) Perioperative complications of holmium laser enucleation of the prostate: experience in the first 280 patients, and a review of literature.BJU Int.100: 94–101.
29.
AhyaiS.A., LehrichK., KuntzR.M.. (2007) Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial.Eur Urol.52: 1456–1463.
30.
WilsonL.C., GillingP.J., WilliamsA., KennettK.M., FramptonC.M., WestenbergA.M. (2006) A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years.Eur Urol.50: 569–573.
31.
RigattiL., NasproR., SaloniaA., CentemeroA., GhezziM., GuazzoniG. (2006) Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up?Urology.67: 1193–1198.
32.
MavuduruR.M., MandalA.K., SinghS.K., AcharyaN., AgarwalM., GargS. (2009) Comparison of HoLEP and TURP in terms of efficacy in the early postoperative period and perioperative morbidity.Urol Int.82: 130–135.
33.
BrigantiA., NasproR., GallinaA., SaloniaA., VavassoriI., HurleR. (2006) Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-center, randomized trial.J Urol.175: 1817–1821.
34.
KuntzR.M., LehrichK., AhyaiS.. (2004) Transurethral holmium laser enucleation of the prostate compared with transvesical open prostatectomy: 18-month follow-up of a randomized trial.J Endourol.18: 189–191.
35.
BrehmerM.. (1997) Morphological changes in prostatic adenomas after transurethral microwave thermotherapy.Br J Urol.80: 123–127.
36.
NissenkornI., RotbardM., SlutzkerD., BernheimJ.. (1993) Connection between the length of the heating antenna and volume of the prostate in transurethral thermotherapy for benign prostatic hyperplasia.Eur Urol.23: 307–311.
37.
DevonecM., OgdenC., PerrinP., St Clair CarterS.. (1993) Clinical response to transurethral microwave thermotherapy is thermal dose dependent.Eur Urol.23: 267–274.
38.
BluteM.L., TomeraK.M., HellersteinD.K., McKielC.F.Jr., LynchJ.H., ReganJ.B. (1993) Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: results of the United States Prostatron Cooperative Study.J Urol.150: 1591–1596.
39.
LarsononT.R., CollinsJ.M., CoricaA.. (1998) Detailed interstitial temperature mapping during treatment with a novel transurethral microwave thermoablation system in patients with benign prostatic hyperplasia.J Urol.159: 258–264.
40.
ThalmannG.N., MatteiA., TreuthardtC., BurkhardF.C., StuderU.E.. (2002) Transurethral microwave therapy in 200 patients with a minimum follow-up of 2 years: urodynamic and clinical results.J Urol.167: 2496–2501.
41.
GravasS., LagunaM.P., de la RosetteJ.J.. (2003) Efficacy and safety of intraprostatic temperature-controlled microwave thermotherapy in patients with benign prostatic hyperplasia: results of a prospective, open-label, single-center study with 1-year follow-up.J Endourol.17: 425–430.
42.
SchulmanC.C., ZlottaA.R., RasorJ.S., HourriezL., NoelJ.C., EdwardsS.D.. (1993) Transurethral needle ablation (TUNA): safety, feasibility, and tolerance of a new office procedure for treatment of benign prostatic hyperplasia.Eur Urol.24: 415–423.
43.
ZlottaA.R., GiannakopoulosX., MaehlumO., OstremT., SchulmanC.C.. (2003) Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centers.Eur Urol.44: 89–93.
44.
de la RosetteJ., GravasbS., MuschtercR., RassweilerdJ., JoyceeA.. on behalf of the members of the board of the ESUT (2003) Present practice and development of minimally invasive techniques, imaging and training in European urology: results of a survey of the European Society of Uro-Technology (ESUT).Eur Urol.44: 346–351.
45.
HoffmanR.M., MacDonaldR., SlatonJ.W., WiltT.. (2003) Laser prostatectomy versus transurethral resection for treating benign prostatic obstruction: a systematic review.J Urol.169: 210–215.
